Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling

BioFactors

Volumn 35, Issue 4, 2009, Pages 338-345

  Hergovich, Alexander ^a   Hemmings, Brian A ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

MOB Mps one binder protein; MST mammalian serine threonine sterile 20 like kinase; STK38 STK38L; Tumor suppressor proto oncogene

Indexed keywords

ADAPTOR PROTEIN; DROSOPHILA PROTEIN; LARGE TUMOR SUPPRESSOR PROTEIN KINASE 1; LARGE TUMOR SUPPRESSOR PROTEIN KINASE 2; MERLIN; NUCLEAR DBF2 RELATED PROTEIN KINASE; ONCOPROTEIN; PROTEIN HIPPO; PROTEIN KINASE; PROTEIN MOB1A; PROTEIN MOB1B; PROTEIN SALVADOR; PROTEIN TAZ; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN; CELL CYCLE PROTEIN; HPO PROTEIN, DROSOPHILA; LATS1 PROTEIN, HUMAN; LATS2 PROTEIN, HUMAN; MOBKL1A PROTEIN, HUMAN; MOBKL1B PROTEIN, HUMAN; MST4 PROTEIN, HUMAN; NDR1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN SERINE THREONINE KINASE; SAV1 PROTEIN, HUMAN; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; STK3 PROTEIN, HUMAN; STK38L PROTEIN, HUMAN; STK4 PROTEIN, HUMAN; TAZ PROTEIN, HUMAN; TRANSCRIPTION FACTOR; YY1AP1 PROTEIN, HUMAN;

CANCER INHIBITION; CARCINOGENESIS; CELL TRANSFORMATION; DROSOPHILA MELANOGASTER; ENZYME REGULATION; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENE EXPRESSION REGULATION; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

EUKARYOTA; MAMMALIA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL CYCLE PROTEINS; DROSOPHILA PROTEINS; GENE EXPRESSION REGULATION; GENES, TUMOR SUPPRESSOR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROFIBROMIN 2; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 70449723123     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.47     Document Type: Review

References (73)

1. Vivanco, I. and Sawyers, C. L. (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489-501.
2. Yuan, T. L. and Cantley, L. C. (2008) PI3K pathway alterations in cancer: variations on a theme. Oncogene 27, 5497-5510.
3. Hergovich, A., Stegert, M. R., Schmitz, D., and Hemmings, B. A. (2006) NDR kinases regulate essential cell processes from yeast to humans. Nat. Rev. Mol. Cell. Biol. 7, 253-264.
4. Bardin, A. J., and Amon, A. (2001) Men and sin: what's the difference? Nat. Rev. Mol. Cell Biol. 2, 815-826.
5. Harvey, K., and Tapon, N. (2007) The Salvador-Warts-Hippo pathway- an emerging tumour-suppressor network. Nat. Rev. Cancer 7, 182-191.
6. Pan, D. (2007) Hippo signaling in organ size control. Genes Dev. 21, 886-897.
7. Reddy, B. V. and Irvine, K. D. (2008) The Fat and Warts signaling pathways: new insights into their regulation, mechanism and conservation. Development 135, 2827-2838.
8. Saucedo, L. J. and Edgar, B. A. (2007) Filling out the Hippo pathway. Nat. Rev. Mol. Cell Biol. 8, 613-621.
9. Hergovich, A., Cornils, H., and Hemmings, B. A. (2008) Mammalian NDR protein kinases: from regulation to a role in centrosome duplication. Biochim. Biophys. Acta. 1784, 3-15.
10. Chan, E. H., Nousiainen, M., Chalamalasetty, R. B., Schafer, A., Nigg, E. A., and Sillje, H. H. (2005) The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24, 2076-2086.
11. Hirabayashi, S., Nakagawa, K., Sumita, K., Hidaka, S., Kawai, T., Ikeda, M., Kawata, A., Ohno, K., and Hata, Y. (2008) Threonine 74 of MOB1 is a putative key phosphorylation site by MST2 to form the scaffold to activate nuclear Dbf2-related kinase 1. Oncogene 27, 4281-4292.
12. Praskova, M., Xia, F., and J., Avruch (2008) MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr. Biol. 18, 311-321.
13. Vichalkovski, A., Gresko, E., Cornils, H., Hergovich, A., Schmitz, D., and Hemmings, B. A. (2008) NDR kinase is activated by RASSF1A/MST1 in response to Fas receptor stimulation and promotes apoptosis. Curr. Biol. 18, 1889-1895.
14. Stegert, M. R., Hergovich, A., Tamaskovic, R., Bichsel, S. J., and Hemmings, B. A. (2005) Regulation of NDR protein kinase by hydrophobic motif phosphorylation mediated by the mammalian Ste20-like kinase MST3. Mol. Cell. Biol. 25, 11019-11029.
15. Emoto, K., Parrish, J. Z., Jan, L. Y., and Jan, Y. N. (2006) The tumour suppressor Hippo acts with the NDR kinases in dendritic tiling and maintenance. Nature 443, 210-213.
16. Wei, X., Shimizu, T., and Lai, Z. C. (2007) Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila. EMBO J. 26, 1772-1781.
17. McClatchey, A. I., Saotome, I., Mercer, K., Crowley, D., Gusella, J. F., Bronson, R. T., and Jacks, T. (1998) Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes. Dev. 12, 1121-1133.
18. Curto, M., Cole, B. K., Lallemand, D., Liu, C. H., and McClatchey, A. I. (2007) Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J. Cell. Biol. 177, 893-903.
19. Lallemand, D., Curto, M., Saotome, I., Giovannini, M., and McClatchey, A. I. (2003) NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev. 17, 1090-1100.
20. Lau, Y. K., Murray, L. B., Houshmandi, S. S., Xu, Y., Gutmann, D. H., and Yu, Q. (2008) Merlin is a potent inhibitor of glioma growth. Cancer Res. 68, 5733-5742.
21. Tikoo, A., Varga, M., Ramesh, V., Gusella, J., and Maruta, H. (1994) An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin) J. Biol. Chem. 269, 23387-23390.
22. Bianchi, A. B., Hara, T., Ramesh, V., Gao, J. P., Klein-Szanto, A. J., Morin, F., Menon, A. G., Trofatter, J. A., Gusella, J. F., Seizinger, B. R., and Kley, N. (1994) Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat. Genet. 6, 185-192.
23. Lee, J. H., Kim, T. S., Yang, T. H., Koo, B. K., Oh, S. P., Lee, K. P., Oh, H. J., Lee, S. H., Kong, Y. Y., Kim, J. M., and Lim, D. S. (2008) A crucial role of WW45 in developing epithelial tissues in the mouse. EMBO J. 27, 1231-1242.
24. Tapon, N., Harvey, K. F., Bell, D. W., Wahrer, D. C., Schiripo, T. A., Haber, D. A., and Hariharan, I. K. (2002) salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110, 467-478.
25. Hao, Y., Chun, A., Cheung, K., Rashidi, B., and Yang, X. (2008) Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J. Biol. Chem. 283, 5496-5509.
26. Seidel, C., Schagdarsurengin, U., Blumke, K., Wurl, P., Pfeifer, G. P., Hauptmann, S., Taubert, H., and Dammann, R. (2007) Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma. Mol. Carcinog. 46, 865-871.
27. Minoo, P., Zlobec, I., Baker, K., Tornillo, L., Terracciano, L., Jass, J. R., and Lugli, A. (2007) Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer. Mod. Pathol. 20, 331-338. (Pubitemid 46348330)
28. Uren, A. G., Kool, J., Matentzoglu, K., de Ridder, J., Mattison, J., van Uitert, M., Lagcher, W., Sie, D., Tanger, E., Cox, T., Reinders, M., Hubbard, T. J., Rogers, J., Jonkers, J., Wessels, L., Adams, D. J., van Lohuizen, M., and Berns, A. (2008) Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks. Cell 133, 727-741.
29. Lai, Z. C., Wei, X., Shimizu, T., Ramos, E., Rohrbaugh, M., Nikolaidis, N., Ho, L. L., and Li, Y. (2005) Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 120, 675-685.
30. Kosaka, Y., Mimori, K., Tanaka, F., Inoue, H., Watanabe, M., and Mori, M. (2007) Clinical significance of the loss of MATS1 mRNA expression in colorectal cancer. Int. J. Oncol. 31, 333-338.
31. St John, M. A., Tao, W., Fei, X., Fukumoto, R., Carcangiu, M. L., Brownstein, D. G., Parlow, A. F., McGrath, J., and Xu, T. (1999) Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat. Genet. 21, 182-186.
32. McPherson, J. P., Tamblyn, L., Elia, A., Migon, E., Shehabeldin, A., Matysiak- Zablocki, E., Lemmers, B., Salmena, L., Hakem, A., Fish, J., Kassam, F., Squire, J., Bruneau, B. G., Hande, M. P., and Hakem, R. (2004) Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. EMBO J. 23, 3677-3688.
33. Yabuta, N., Okada, N., Ito, A., Hosomi, T., Nishihara, S., Sasayama, Y., Fujimori, A., Okuzaki, D., Zhao, H., Ikawa, M., Okabe, M., and Nojima, H. (2007) Lats2 is an essential mitotic regulator required for the coordination of cell division. J. Biol. Chem. 282, 19259-19271.
34. Xia, H., Qi, H., Li, Y., Pei, J., Barton, J., Blackstad, M., Xu, T., and Tao, W. (2002) LATS1 tumor suppressor regulates G2/M transition and apoptosis. Oncogene 21, 1233-1241.
35. Zhang, J., Smolen, G. A., and Haber, D. A. (2008) Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. Cancer Res. 68, 2789-2794.
36. Li, Y., Pei, J., Xia, H., Ke, H., Wang, H., and Tao, W. (2003) Lats2, a putative tumor suppressor, inhibits G1/S transition. Oncogene 22, 4398-4405.
37. Chakraborty, S., Khare, S., Dorairaj, S. K., Prabhakaran, V. C., Prakash, D. R., and Kumar, A. (2007) Identification of genes associated with tumorigenesis of retinoblastoma by microarray analysis. Genomics 90, 344-353. (Pubitemid 47176334)
38. Suzuki, T., Shen, H., Akagi, K., Morse, H. C., Malley, J. D., Naiman, D. Q., Jenkins, N. A., and Copeland, N. G. (2002) New genes involved in cancer identified by retroviral tagging. Nat. Genet. 32, 166-174.
39. Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., and Pan, D. (2007) Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120-1133.
40. Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., and Brummelkamp, T. R. (2007) YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 17, 2054-2060.
41. Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S. T., Luk, J. M., Wigler, M., Hannon, G. J., Mu, D., Lucito, R., Powers, S., and Lowe, S. W. (2006) Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125, 1253-1267.
42. Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., Zheng, P., Ye, K., Chinnaiyan, A., Halder, G., Lai, Z. C., and Guan, K. L. (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747-2761.
43. Overholtzer, M., Zhang, J., Smolen, G. A., Muir, B., Li, W., Sgroi, D. C., Deng, C. X., Brugge, J. S., and Haber, D. A. (2006) Transforming properties of YAP a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl. Acad. Sci. USA 103, 12405-12410.
44. Striedinger, K., VandenBerg, S. R., Baia, G. S., McDermott, M. W., Gutmann, D. H., and Lal, A. (2008) The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP. Neoplasia 10, 1204-1212.
45. Steinhardt, A. A., Gayyed, M. F., Klein, A. P., Dong, J., Maitra, A., Pan, D., Montgomery, E. A., and Anders, R. A. (2008) Expression of Yes-associated protein in common solid tumors. Hum. Pathol. 39, 1582-1589.
46. Lei, Q. Y., Zhang, H., Zhao, B., Zha, Z. Y., Bai, F., Pei, X. H., Zhao, S., Xiong, Y., and Guan, K. L. (2008) TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol. Cell Biol. 28, 2426-2436.
47. Chan, S. W., Lim, C. J., Guo, K., Ng, C. P., Lee, I., Hunziker, W., Zeng, Q., and Hong W. (2008) A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res. 68, 2592-2598.
48. Hong, J. H., Hwang, E. S., McManus, M. T., Amsterdam, A., Tian, Y., almukova, R., Mueller, E., Benjamin, T., Spiegelman, B. M., Sharp, P. A., Hopkins, N., and Yaffe, M. B. (2005) TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309, 1074-1078.
49. McClatchey, A. I., Saotome, I., Ramesh, V., Gusella, J. F., and Jacks, T. (1997) The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes Dev. 11, 1253-1265.
50. Morin-Kensicki, E. M., Boone, B. N., Howell, M., Stonebraker, J. R., Teed, J., Alb, J. G., Magnuson, T. R., O'Neal, W., and Milgram, S. L. (2006) Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65. Mol. Cell. Biol. 26, 77-87.
51. Hossain, Z., Ali, S. M., Ko, H. L., Xu, J., Ng, C. P., Guo, K., Qi, Z., Ponniah, S., Hong, W., and Hunziker, W. (2007) Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1. Proc. Natl. Acad. Sci. USA 104, 1631-1636.
52. Makita, R., Uchijima, Y., Nishiyama, K., Amano, T., Chen, Q., Takeuchi, T., Mitani, A., Nagase, T., Yatomi, Y., Aburatani, H., Nakagawa, O., Small, E. V., Cobo-Stark, P., Igarashi, P., Murakami, M., Tominaga, J., Sato, T., Asano, T., Kurihara, Y., and Kurihara, H. (2008) Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ. Am. J. Physiol. Renal. Physiol. 294, F542-F553.
53. Tian, Y., Kolb, R., Hong, J. H., Carroll, J., Li, D., You, J., Bronson, R., Yaffe, M. B., Zhou, J., and Benjamin, T. (2007) TAZ promotes PC2 degradation through a SCFβ-Trcp E3 ligase complex. Mol. Cell. Biol. 27, 6383-6395.
54. Yokoyama, T., Osada, H., Murakami, H., Tatematsu, Y., Taniguchi, T., Kondo, Y., Yatabe, Y., Hasegawa, Y., Shimokata, K., Horio, Y., Hida, T., and Sekido, Y. (2008) YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation. Carcinogenesis 29, 2139-2146.
55. Ling, P., Lu, T. J., Yuan, C. J., and Lai, M. D. (2008) Biosignaling of mammalian Ste20-related kinases. Cell Signal 20, 1237-1247.
56. Wu, S., Huang, J., Dong, J., and Pan, D. (2003) hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 114, 445-456.
57. Oka, T., Mazack, V., and Sudol, M. (2008) Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). J. Biol. Chem. 283, 27534-27546.
58. Guo, C., Tommasi, S., Liu, L., Yee, J. K., Dammann, R., and Pfeifer, G. P. (2007) RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. Curr. Biol. 17, 700-705.
59. Matallanas, D., Romano, D., Yee, K., Meissl, K., Kucerova, L., Piazzolla, D., Baccarini, M., Vass, J. K., Kolch, W., and O'Neill, E. (2007) RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol. Cell. 27, 962-975.
60. Oh, H. J., Lee, K. K., Song, S. J., Jin, M. S., Song, M. S., Lee, J. H., Im, C. R., Lee, J. O., Yonehara, S., and Lim, D. S. (2006) Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis. Cancer Res. 66, 2562-2569.
61. Bichsel, S. J., Tamaskovic, R., Stegert, M. R., and Hemmings, B. A. (2004) Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein. J. Biol. Chem. 279, 35228-35235.
62. Stavridi, E. S., Harris, K. G., Huyen, Y., Bothos, J., Verwoerd, P. M., Stayrook, S. E., Pavletich, N. P., Jeffrey, P. D., and Luca, F. C. (2003) Crystal structure of a human Mob1 protein: toward understanding Mobregulated cell cycle pathways. Structure 11, 1163-1170.
63. Tao, W., Zhang, S., Turenchalk, G. S., Stewart, R. A., St. John, M. A., Chen, W., and Xu, T. (1999) Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity. Nat. Genet. 21, 177-181.
64. Aylon, Y., Michael, D., Shmueli, A., Yabuta, N., Nojima, H., and Oren, M. (2006) A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev. 20, 2687-2700.
65. Hergovich, A., Lamla, S., Nigg, E. A., and Hemmings, B. A. (2007) Centrosome- associated NDR kinase regulates centrosome duplication. Mol. Cell 25, 625-634.
66. Rowland, B. D., and Peeper, D. S. (2006) KLF4, p21 and context-dependent opposing forces in cancer. Nat. Rev. Cancer. 6, 11-23.
67. Komuro, A., Nagai, M., Navin, N. E., and Sudol, M. (2003) WW domaincontaining protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J. Biol. Chem. 278, 33334-33341.
68. Levy, D., Adamovich, Y., Reuven, N., and Shaul, Y. (2008) Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol. Cell 29, 350-361.
69. Lapi, E., Di Agostino, S., Donzelli, S., Gal, H., Domany, E., Rechavi, G., Pandolfi, P. P., Givol, D., Strano, S., Lu, X., and Blandino, G. (2008) PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol. Cell 32, 803-814.
70. Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R. C., and Melton, D. A. (2002) "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298, 597-600.
71. Varelas, X., Sakuma, R., Samavarchi-Tehrani, P., Peerani, R., Rao, B. M., Dembowy, J., Yaffe, M. B., Zandstra, P. W., and Wrana, J. L. (2008) TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat. Cell. Biol. 10, 837-848.
72. Larsson, J., Ohishi, M., Garrison, B., Aspling, M., Janzen, V., Adams, G. B., Curto, M., McClatchey, A. I., Schipani, E., and Scadden, D. T. (2008) Nf2/merlin regulates hematopoietic stem cell behavior by altering microenvironmental architecture. Cell Stem Cell 3, 221-227.
73. Kawahara, M., Hori, T., Chonabayashi, K., Oka, T., Sudol, M., and Uchiyama, T. (2008) Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73. Blood 112, 3856-3866.